The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Forecasted Market Size Of The Prenatal And Newborn Genetic Testing Market Compare Between 2026 And 2030?
The prenatal and newborn genetic testing market has experienced rapid expansion recently. This market is projected to expand from $7.6 billion in 2025 to $8.51 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.0%. Historically, this growth has been driven by factors such as a greater understanding of genetic conditions, the broadening of maternal and neonatal healthcare provisions, an increase in institutional screening initiatives, the accessibility of diagnostic labs, and enhancements in the precision of genetic testing.
The prenatal and newborn genetic testing market is anticipated to experience substantial growth over the upcoming years. Its size is projected to reach $13.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This expansion during the forecast period is driven by factors such as the increasing embrace of personalized medicine approaches, a heightened need for early-stage disease detection, the broader implementation of newborn screening mandates, growing investments in genomics infrastructure, and the rising utilization of digital health platforms. Noteworthy trends for the forecast period encompass the wider adoption of non-invasive prenatal testing, increased application of advanced genetic screening panels, the growing integration of AI in genetic risk analysis, the expansion of high-throughput sequencing platforms, and an enhanced focus on the prompt detection of congenital disorders.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp
Which Growth Factors Are Strengthening The Prenatal And Newborn Genetic Testing Market Landscape?
The prenatal and newborn genetic testing market is expected to grow as the incidence of genetic disorders increases. Genetic disorders are medical conditions that arise from abnormalities or mutations in an individual’s DNA or genetic material. Prenatal and newborn genetic testing enables the identification of these disorders at an early stage, often before symptoms appear, allowing healthcare providers to initiate timely interventions and treatment strategies. For instance, in May 2024, the Centers for Disease Control and Prevention (CDC), a US public health agency, reported that sickle cell disease (SCD) impacts about 100,000 people in the United States. More than 90% of those affected are non-Hispanic Black or African American, while an estimated 3%-9% are Hispanic or Latino. Therefore, the rising prevalence of genetic disorders is a significant driver for the prenatal and newborn genetic testing market.
How Is The Prenatal And Newborn Genetic Testing Market Examined Through Segment Analysis?
The prenatal and newborn genetic testing market covered in this report is segmented –
1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers
Subsegments:
1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers
Which Trends Are Influencing The Expansion Of The Prenatal And Newborn Genetic Testing Market?
Leading companies in the premature ejaculation treatment market are actively developing new solutions, including delay sprays, to boost their revenues. Delay sprays are specialized products applied to the penis before sexual activity, designed to help men prolong intercourse by temporarily desensitizing penis nerves, which reduces sensitivity and postpones ejaculation. For instance, in August 2023, Maude, a US-based sexual wellness company, introduced ‘Stay,’ a delay spray specifically created to address premature ejaculation. This product contains 10% lidocaine, a fast-evaporating local anesthetic that decreases sensitivity in the male genital region. Additionally, ‘Stay’ is compatible with both latex and polyisoprene condoms, alongside various lubricants and devices. It is also vegan-friendly, fragrance-free, and free from sulfates, silicones, and parabens.
Who Are The Businesses Driving Activity In The Prenatal And Newborn Genetic Testing Market?
Major companies operating in the prenatal and newborn genetic testing market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostic Incorporated, Agilent Technologies Inc, Illumina Inc, PerkinElmer Genomics, Quidel Corporation, Bio Rad Laboratories Inc, Qiagen NV, Werfen SA, DiaSorin SpA, BGI Group, Natera Inc, Trinity Biotech plc, Meridian Bioscience Inc, Sekisui Diagnostics, Ariosa Diagnostics Inc, AccuBioTech Co Ltd, Sequenom Inc, Roche Diagnostics International AG
Access The Complete Prenatal And Newborn Genetic Testing Market Report:
Which Region Has The Strongest Presence In The Prenatal And Newborn Genetic Testing Market?
North America was the largest region in the prenatal and newborn genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Prenatal And Newborn Genetic Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp
Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2026, By The Business Research Company
Infertility Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report
Precocious Puberty Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/precocious-puberty-treatment-global-market-report
Fertility Treatments Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model